Highlights and Quick Summary
- Investing cash flow for the quarter ending February 28, 2023 was $8.66 Million (a -782.77% decrease compared to previous quarter)
- Year-over-year quarterly Investing cash flow decreased by -78.73%
- Annual Investing cash flow for 2022 was $34.6 Million (a -138.13% decrease from previous year)
- Annual Investing cash flow for 2021 was $-90.8 Million (a -11.69% decrease from previous year)
- Annual Investing cash flow for 2020 was $-103 Million (a 191.33% increase from previous year)
- Twelve month Investing cash flow ending February 28, 2023 was $17.4 Million (a -280.97% decrease compared to previous quarter)
- Twelve month trailing Investing cash flow decreased by -75.19% year-over-year
Trailing Investing cash flow for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| $17.4 Million | $-9.6 Million | $34.6 Million | $70.1 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Investing cash flow of Organigram Holdings Inc.
Most recent Investing cash flowof OGI including historical data for past 10 years.Interactive Chart of Investing cash flow of Organigram Holdings Inc.
Organigram Holdings Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $8.66 | – | – | – | – |
| 2022 | $-1.27 | $-30.7 | $40.69 | $-18.33 | $34.62 |
| 2021 | $42.95 | $4.73 | $-122.34 | $14.81 | $-90.79 |
| 2020 | $12.01 | $-30.72 | $-20.43 | $-25.98 | $-102.8 |
| 2019 | $-25.68 | $5.22 | $-12.64 | $-9.51 | $-35.29 |
| 2018 | – | – | $-18.36 | $-76.74 | $-76.74 |
| 2017 | – | – | – | – | $-31.49 |
| 2016 | – | – | – | – | $-20.76 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic